Company News

CYTENA BPS launches C.NEST – a robust, flexible & reliable microbioreactor

Twitter Facebook Linkedin Envelope We are proud to announce that we have launched the C.NEST – A robust, flexible & reliable system for everyday culturing.The C.NEST microbioreactor provides outstanding flexibility in static and mixing culture conditions, supports superior cell growth and maintenance of a variety of cell lines and mammalian cells with customizable mixing levels,

CYTENA BPS launches C.NEST – a robust, flexible & reliable microbioreactor Read More »

CYTENA launches new generation of B.SIGHT, a fully automated single-cell dispenser for microorganisms

Twitter Facebook Linkedin Envelope CYTENA’s B.SIGHTTM will reduce timelines and cut costs on single-cell microbiology research Freiburg, Germany -PRESS RELEASE-CYTENA, a BICO group company (Nasdaq Stockholm: BICO) and leading provider of high-precision instruments for handling biological cells, has launched a new instrument to streamline single-cell isolation in microbiology research. The next generation B.SIGHT is taking the

CYTENA launches new generation of B.SIGHT, a fully automated single-cell dispenser for microorganisms Read More »

B2Run Freiburg 2022

Twitter Facebook Linkedin Envelope Yesterday, we took our teamwork skills from the lab to the streets for the annual B2Run in Freiburg! It’s been a couple of years since our last B2Run, but the team was ready and eager to take on the 5.2 km challenge together. And keeping with CYTENA tradition, we ran the

B2Run Freiburg 2022 Read More »

CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development

Twitter Facebook Linkedin Envelope CYTENA’s C.STATION™ and ExcellGene’s CHOExpress® will Reduce Timelines to Generate Clonal Cell Lines Freiburg, Germany & Monthey, Switzerland – PRESS RELEASE- Today, CYTENA, a BICO group company (Nasdaq Stockholm: BICO) and a leading provider of high-precision instruments for handling biological cells, has entered a collaboration agreement with ExcellGene SA, a leading biologics

CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development Read More »

CYTENA has received the Jobmotor 2021 award for job growth

Twitter Facebook Linkedin Envelope We are thrilled to announce that CYTENA has received the Jobmotor 2021 award for job growth!Dozens of companies across Southern Germany competed to see whose ideas and innovation led to significant job growth in 2021, despite the Coronavirus crisis.https://player.vimeo.com/video/699215950?h=f81679101b&dnt=1&app_id=122963It is truly wonderful to see our team recognized for its talent and

CYTENA has received the Jobmotor 2021 award for job growth Read More »

CYTENA Signs USD 10 Million Deal to Distribute Single Cell Isolators in China to Accelerate Development of Next Generation Therapies

Twitter Facebook Linkedin Envelope The 2-year deal with Applitech Pharmaceutical Equipment Technology further strengthens BICO’s close collaboration and will see nearly 100 of CYTENA’s latest portfolio of cell isolators including the UP.SIGHT to be distributed to the massive Chinese life science market Today CYTENA, a BICO company, announced it has signed a 2-year deal with Applitech

CYTENA Signs USD 10 Million Deal to Distribute Single Cell Isolators in China to Accelerate Development of Next Generation Therapies Read More »

BICO’s group companies CELLINK and CYTENA win five German Design Awards for Excellent Product Design

Twitter Facebook Linkedin Envelope The prestigious awards validate the BICO’s Bio Convergence agenda and comes on the 10th anniversary of the widely respected design competition Five products from BICO, the world’s leading Bio Convergence company, has been awarded with the prestigious 2022 German Design Awards. The recognition comes from the widely respected German Design Council and

BICO’s group companies CELLINK and CYTENA win five German Design Awards for Excellent Product Design Read More »

CYTENA launches C.STATION, a fully automated platform for stable cell line development to streamline production of antibody and gene therapies

Twitter Facebook Linkedin Envelope Today CYTENA, a BICO company, launched C.STATION, a new platform for fully automated stable cell line development. The platform combines CYTENA’s already proven single cell dispensing technology along with its best-in-class liquid handling expertise to enable affordable and high-quality laboratory automation. This combination of technologies advances BICO’s Bio Convergence agenda and democratizes access to

CYTENA launches C.STATION, a fully automated platform for stable cell line development to streamline production of antibody and gene therapies Read More »

CYTENA launches C.LIVE Tox, reagents for real-time direct detection of cytotoxicity

Twitter Facebook Linkedin Envelope We are thrilled to introduce our new C.LIVE Tox reagents! Made for easy real-time direct detection of cytotoxicity C.LIVE Tox Green and Red are sensitive DNA-binding dyes that are nonpermeable to viable cells and nonfluorescent on the outside. After entering dead cells through damaged plasma membranes and binding to DNA, the reagent emits

CYTENA launches C.LIVE Tox, reagents for real-time direct detection of cytotoxicity Read More »